1 - 1 / 1 1 |
1. Nucleotide-binding oligomerization domain 1/Toll-like receptor 4 co-engagement promotes non-specific immune response against K562 cancer cells Samo Guzelj, Žiga Jakopin, 2022, original scientific article Keywords: NOD1 agonist, TLR4 agonist, LPS, synergy, cytolytic activity, PBMC, NK cells, K562 |